A Day Up For Avenue Therapeutics, Inc.
Mon, Nov 29, 2021 at 05:30 PM
Avenue Therapeutics, Inc. (ATXI:NASDAQ) rocketted at $1.7, a gain of 53.2%. The stock appeared on our News Catalysts scanner on Mon, Nov 29, 2021 at 09:48 AM in the 'BIOTECH' category. From Fri, Nov 12, 2021, the stock recorded 22.22% Up Days and 40.00% Green Days
About Avenue Therapeutics, Inc. (ATXI:NASDAQ)
Avenue Therapeutics Inc is a specialty pharmaceutical company focused on the development and commercialization of an intravenous, or IV, formulation of tramadol HCl, or IV Tramadol, for the management of moderate to moderately severe postoperative pain.
Top 10 Gainers:
- iFresh Inc. (IFMK:NASDAQ), 180.37%
- Krystal Biotech, Inc. (KRYS:NASDAQ), 121.65%
- PTPI (PTPI:NASDAQ), 91.39%
- ADGI (ADGI:NASDAQ), 86.43%
- Palatin Technologies, Inc. (PTN:NYSEMKT), 53.34%
- Avenue Therapeutics, Inc. (ATXI:NASDAQ), 53.15%
- AERC (AERC:NASDAQ), 44.88%
- VOSO (VOSO:NASDAQ), 43.95%
- cbdMD, Inc. (YCBD:NYSEMKT), 30.2%
- iBio, Inc. (IBIO:NYSEMKT), 29.15%